Skip to main navigation Skip to search Skip to main content

In vivo siRNA delivery with dendritic poly(l-lysine) for the treatment of hypercholesterolemia

  • Kazuto Watanabe
  • , Mariko Harada-Shiba
  • , Akira Suzuki
  • , Risa Gokuden
  • , Ryohsuke Kurihara
  • , Yusuke Sugao
  • , Takeshi Mori
  • , Yoshiki Katayama
  • , Takuro Niidome

    Research output: Contribution to journal › Article › peer-review

    Abstract

    Intravenous delivery of apolipoprotein B-specific siRNA with a sixth-generation of dendritic poly(l-lysine) (KG6) resulted in siRNA-mediated knockdown of ApoB in healthy C57BL/6 mice without hepatotoxicity, and with a significant reduction of serum low-density lipoprotein cholesterol in apolipoprotein E-deficient mice.

    Original languageEnglish
    Pages (from-to)1306-1310
    Number of pages5
    JournalMolecular BioSystems
    Volume5
    Issue number11
    DOIs
    Publication statusPublished - 2009

    All Science Journal Classification (ASJC) codes

    • Biotechnology
    • Molecular Biology

    Fingerprint

    Dive into the research topics of 'In vivo siRNA delivery with dendritic poly(l-lysine) for the treatment of hypercholesterolemia'. Together they form a unique fingerprint.

    Cite this